{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/17/3313442/0/en/Ocular-Therapeutix-Investor-Day-to-Highlight-U-S-FDA-Alignment-on-AXPAXLI-NDA-with-Submission-Planned-for-Fourth-Quarter-2026.html", "message": "News view counter 804424 successfully enlarged"}